Anemia, Bone Mineral, and Comorbidities
Key Takeaways
- Renal anemia results primarily from decreased erythropoietin production; iron studies (ferritin, TSAT) guide therapy alongside ESAs.
- CKD-MBD involves phosphate retention, calcium imbalance, and secondary hyperparathyroidism — KDIGO targets guide nursing education and monitoring.
- Phosphate binders must be taken with meals; non-calcium binders are preferred when calcium or Ca×P product is elevated.
- Diabetes and cardiovascular disease are the dominant CKD comorbidities; glycemic and blood pressure control affect progression and dialysis outcomes.
- Malnutrition-inflammation complex lowers albumin and confounds nutritional assessment — look at trend, nPCR, and clinical intake.
Anemia, Bone Mineral, and Comorbidities
Quick Answer: Renal anemia follows EPO deficiency plus iron restriction; treat with iron repletion and erythropoiesis-stimulating agents (ESAs) per protocol. CKD-mineral and bone disorder (CKD-MBD) means high phosphate, abnormal calcium, and elevated PTH — nurses teach binder timing and monitor Ca×P product. Diabetes and cardiovascular disease drive most dialysis morbidity.
These complications explain why dialysis patients feel exhausted, itch, fracture bones, and die from cardiovascular events. CDN Domain 1 items test nursing monitoring, patient teaching, and when lab trends require nephrology/pharmacy follow-up.
Renal Anemia Pathophysiology
As GFR falls, peritubular fibroblasts produce less erythropoietin (EPO). Anemia develops gradually:
| Stage | Typical hemoglobin trend | Symptoms |
|---|---|---|
| CKD G3–G4 | Hgb drifts toward 10–11 g/dL | Fatigue, decreased exercise tolerance |
| Dialysis | Often target 10–11 g/dL per facility/KDIGO-influenced policy | Dyspnea, angina worsening, cognitive slowing |
Iron deficiency worsens ESA resistance. Monitor:
| Test | Dialysis nursing interpretation |
|---|---|
| Ferritin | Iron stores; very high may reflect inflammation |
| TSAT (transferrin saturation) | Functional iron availability; low TSAT limits EPO response |
| Hgb/Hct | Trend more important than single value |
ESA therapy (epoetin alfa, darbepoetin) requires monitoring blood pressure — hypertension can worsen. IV iron is common in HD because ongoing blood loss in the circuit and inflammation increase iron needs.
Exam trap: Transfuse aggressively to Hgb >12 without indication — KDIGO-era practice favors ESA + iron with cautious transfusion because higher Hgb targets increased cardiovascular risk in trials.
CKD-MBD: Phosphate, Calcium, PTH
CKD-MBD is the spectrum of biochemical, bone, and vascular abnormalities from failing phosphate excretion and disturbed vitamin D metabolism.
| Parameter | Common dialysis target range (KDIGO-influenced) | Nursing focus |
|---|---|---|
| Phosphorus | ~3.5–5.5 mg/dL | Diet, binders, adherence |
| Corrected calcium | ~8.4–10.2 mg/dL | Avoid hypercalcemia with calcium-based binders |
| iPTH | Roughly 2–9× upper limit normal on dialysis | Secondary hyperparathyroidism management |
| Ca×P product | Keep <55 mg²/dL² | Vascular calcification risk when elevated |
Secondary hyperparathyroidism develops when high phosphate and low active vitamin D stimulate PTH secretion. Severe disease causes renal osteodystrophy — bone pain, fractures, and vascular calcification.
Phosphate Binders and Nursing Teaching
| Binder class | Examples | Key teaching |
|---|---|---|
| Calcium-based | Calcium acetate, calcium carbonate | Cheap; risk hypercalcemia when Ca already high |
| Non-calcium | Sevelamer, lanthanum | Preferred when Ca or Ca×P elevated |
| Iron-based | Ferric citrate, sucroferric oxyhydroxide | Dual phosphate and iron benefit |
Critical teaching point: binders work only when taken with the first bite of food containing phosphate. Binders taken 30 minutes before meals bind little dietary phosphate — a favorite CDN item.
Dietary counseling targets phosphate additives (processed meats, colas with phosphoric acid) — organic phosphorus in plants is less absorbed.
Vitamin D and Calcimimetics (Nursing Awareness)
Nephrologists prescribe active vitamin D analogs (calcitriol, paricalcitol) to suppress PTH. Nurses watch for hypercalcemia and hyperphosphatemia worsening. Calcimimetics (cinacalcet) lower PTH by sensitizing the calcium-sensing receptor — monitor for hypocalcemia and nausea.
You are not expected to select drug doses on CDN — you recognize side effects, lab trends, and patient education needs.
Diabetes and Cardiovascular Comorbidity
Most U.S. dialysis patients have diabetes and/or hypertension. Nursing implications:
| Comorbidity | Dialysis-specific concern |
|---|---|
| Diabetes | Glycemic variability with meals, dialysate glucose (PD), foot care with neuropathy |
| Hypertension | Volume-dependent BP — address dry weight and sodium |
| CAD/heart failure | UF goals, ischemia during HD hypotension, careful fluid removal |
| Peripheral vascular disease | AV access surveillance, wound healing |
Malnutrition-inflammation syndrome lowers serum albumin independent of intake. Use dietary recall, SGA, nPCR, and handgrip when available — do not blame patients solely for low albumin.
Worked Exam Scenario
A HD patient has phosphorus 7.2 mg/dL, corrected calcium 10.3 mg/dL, Ca×P 74, and takes calcium acetate inconsistently before meals (often 30 minutes early). Which nursing plan is highest priority?
Plan: Teach binder timing with first bite; coordinate with nephrologist to switch from calcium-based to non-calcium binder given hypercalcemia and elevated Ca×P; reinforce low-phosphate diet including additive avoidance; recheck labs per protocol. Increasing calcium acetate would worsen hypercalcemia.
Common CDN Traps
- Binder timing errors in answer choices
- Assuming low albumin always means poor diet (inflammation matters)
- Targeting Hgb >12 as default ESA goal
- Ignoring Ca×P product when only phosphorus is listed
Study Routine
- Memorize Ca×P calculation (multiply Ca × phos)
- State ferritin/TSAT roles in one sentence each
- List three high-phosphate foods and three additive sources
Final Check
Explain renal anemia mechanism, binder timing rule, and when non-calcium binders are preferred — without notes.
Inflammation and Functional Iron Deficiency
Chronic inflammation elevates hepcidin, lowering TSAT despite ferritin that appears adequate. Pattern: ferritin >500 ng/mL with TSAT <20% may reflect inflammation — follow nephrology protocol rather than reflexively stopping iron. Reassess anemia management after hospitalization or access infection when inflammation spikes.
Cardiovascular Risk Reduction Nursing
CKD is a coronary disease equivalent in risk stratification. Nursing contributions tested on CDN:
- Blood pressure at goal before and after dialysis — avoid both uncontrolled HTN and intradialytic hypotension
- Smoking cessation referral and statin adherence when prescribed
- Dialysis dose and access function — inadequate clearance worsens uremic cardiomyopathy
- Volume control — chronic overload strains LV function
When a stem pairs low Hgb with high ferritin and low TSAT, think functional iron deficiency with inflammation before selecting transfusion.
A hemodialysis patient has hemoglobin 9.2 g/dL, ferritin 150 ng/mL, and TSAT 18%. The nephrologist plans anemia management. Which factor most limits erythropoiesis-stimulating agent effectiveness in this profile?
A patient takes sevelamer carbonate but swallows all doses on an empty stomach 30 minutes before meals for fewer GI side effects. Phosphorus remains 6.9 mg/dL. What is the best nursing intervention?
Which laboratory combination most strongly signals elevated vascular calcification risk requiring coordinated nephrology and dietary follow-up?